Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213316481> ?p ?o ?g. }
- W4213316481 abstract "Objective: To summarize the current therapeutic status using chemotherapeutic agent docetaxel and endocrine therapeutic agents (ARAT, abiraterone, orteronel or enzalutamide) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), including sequential therapy and combined therapy, to promote the consensus on the optimal regimen for achieving superior treatment efficacy. Methods: Through literature search in PubMed, articles with the following relevant keywords were collected and anlyzed: CRPC, abiraterone, orteronel and enzalutamide, median survival, overall survival, prostate specific antigen (PSA), PSA response rate and median radiologic progression-free survival. Results: Fifty-eight articles were obtained and analyzed in this review. These articles included androgen axis-targeting agents after docetaxel, docetaxel after androgen axis-targeting agents, Triple sequential and combination therapy, covering four current drugs for mCRPC treatment: docetaxel, abiraterone, orteronel, and enzalutamide. It was found that there may be some cross-resistance between androgen axis-targeting agents, which will reduce the efficacy of subsequent drug treatment. Although neither of the studies of using combination therapy showed serious drug toxicity, the efficacy of sequential therapy was not as good as expected. Most adverse reactions after treatment were reported to be level 1–2. Conclusion: Based on the results of the current studies, abiraterone followed by enzalutamide treatment is the best sequential treatment for most docetaxel-naïve patients. This treatment achieves not only good OS, but also PFS and PSA response rates. In addition, for patients who have previously failed docetaxel treatment, enzalutamide is the best choice as the subsequent treatment." @default.
- W4213316481 created "2022-02-24" @default.
- W4213316481 creator A5003276234 @default.
- W4213316481 creator A5025314440 @default.
- W4213316481 creator A5027241541 @default.
- W4213316481 creator A5029053393 @default.
- W4213316481 creator A5044867727 @default.
- W4213316481 creator A5049077014 @default.
- W4213316481 creator A5061906067 @default.
- W4213316481 creator A5062680050 @default.
- W4213316481 creator A5030654988 @default.
- W4213316481 date "2022-02-17" @default.
- W4213316481 modified "2023-10-05" @default.
- W4213316481 title "Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?" @default.
- W4213316481 cites W1500716003 @default.
- W4213316481 cites W1512914561 @default.
- W4213316481 cites W1965002585 @default.
- W4213316481 cites W1996389184 @default.
- W4213316481 cites W2006213437 @default.
- W4213316481 cites W2014751188 @default.
- W4213316481 cites W2026540083 @default.
- W4213316481 cites W2027081726 @default.
- W4213316481 cites W2045589622 @default.
- W4213316481 cites W2052153800 @default.
- W4213316481 cites W2066112327 @default.
- W4213316481 cites W2074649788 @default.
- W4213316481 cites W2077244514 @default.
- W4213316481 cites W2080134152 @default.
- W4213316481 cites W2080439368 @default.
- W4213316481 cites W2081365151 @default.
- W4213316481 cites W2088318211 @default.
- W4213316481 cites W2095950698 @default.
- W4213316481 cites W2107798431 @default.
- W4213316481 cites W2110534364 @default.
- W4213316481 cites W2116607127 @default.
- W4213316481 cites W2118564089 @default.
- W4213316481 cites W2119504728 @default.
- W4213316481 cites W2120292596 @default.
- W4213316481 cites W2121023961 @default.
- W4213316481 cites W2131059659 @default.
- W4213316481 cites W2137467802 @default.
- W4213316481 cites W2138137905 @default.
- W4213316481 cites W2148643283 @default.
- W4213316481 cites W2155466895 @default.
- W4213316481 cites W2166305340 @default.
- W4213316481 cites W2166918329 @default.
- W4213316481 cites W2329080756 @default.
- W4213316481 cites W2479762267 @default.
- W4213316481 cites W2571911137 @default.
- W4213316481 cites W2588741549 @default.
- W4213316481 cites W2608121362 @default.
- W4213316481 cites W2769163590 @default.
- W4213316481 cites W2770702948 @default.
- W4213316481 cites W2884762657 @default.
- W4213316481 cites W2900586023 @default.
- W4213316481 cites W2922348865 @default.
- W4213316481 cites W2938497258 @default.
- W4213316481 cites W2951071083 @default.
- W4213316481 cites W2954461020 @default.
- W4213316481 cites W2967692526 @default.
- W4213316481 cites W2984712394 @default.
- W4213316481 cites W2989894179 @default.
- W4213316481 cites W2995441292 @default.
- W4213316481 doi "https://doi.org/10.3389/fphar.2022.843110" @default.
- W4213316481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35250590" @default.
- W4213316481 hasPublicationYear "2022" @default.
- W4213316481 type Work @default.
- W4213316481 citedByCount "2" @default.
- W4213316481 countsByYear W42133164812022 @default.
- W4213316481 crossrefType "journal-article" @default.
- W4213316481 hasAuthorship W4213316481A5003276234 @default.
- W4213316481 hasAuthorship W4213316481A5025314440 @default.
- W4213316481 hasAuthorship W4213316481A5027241541 @default.
- W4213316481 hasAuthorship W4213316481A5029053393 @default.
- W4213316481 hasAuthorship W4213316481A5030654988 @default.
- W4213316481 hasAuthorship W4213316481A5044867727 @default.
- W4213316481 hasAuthorship W4213316481A5049077014 @default.
- W4213316481 hasAuthorship W4213316481A5061906067 @default.
- W4213316481 hasAuthorship W4213316481A5062680050 @default.
- W4213316481 hasBestOaLocation W42133164811 @default.
- W4213316481 hasConcept C121608353 @default.
- W4213316481 hasConcept C126322002 @default.
- W4213316481 hasConcept C143998085 @default.
- W4213316481 hasConcept C197934379 @default.
- W4213316481 hasConcept C2776421732 @default.
- W4213316481 hasConcept C2776551883 @default.
- W4213316481 hasConcept C2776694085 @default.
- W4213316481 hasConcept C2776999253 @default.
- W4213316481 hasConcept C2777899217 @default.
- W4213316481 hasConcept C2778971682 @default.
- W4213316481 hasConcept C2780192828 @default.
- W4213316481 hasConcept C2781190966 @default.
- W4213316481 hasConcept C2781413609 @default.
- W4213316481 hasConcept C61367390 @default.
- W4213316481 hasConcept C71924100 @default.
- W4213316481 hasConcept C98274493 @default.
- W4213316481 hasConceptScore W4213316481C121608353 @default.
- W4213316481 hasConceptScore W4213316481C126322002 @default.
- W4213316481 hasConceptScore W4213316481C143998085 @default.
- W4213316481 hasConceptScore W4213316481C197934379 @default.